Search Results - "ALDRIGHETTI, D"

Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial by BOCCARDO, F, RUBAGOTTI, A, BOLOGNESI, A, ALDRIGHETTI, D, FARRIS, A, AMOROSO, D, MESITI, M, ROMEO, D, SISMONDI, P, GIAI, M, GENTA, F, PACINI, P, DISTANTE, V

“…PURPOSE: To compare the efficacy of chemotherapy versus that of tamoxifen plus ovarian suppression in pre-/perimenopausal estrogen receptor–positive patients…”
Get full text

Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety by BALDINI, E, PROCHILO, T, CONTE, P. F, ORLANDINI, C, BRUZZI, P, SALVADORI, B, BOLOGNESI, A, ALDRIGHETTI, D, VENTURINI, M, ROSSO, R, CARNINO, F, GALLO, L, GIANNESSI, P

“…The aim of the study was to evaluate cardiac safety of two different schedules of Epirubicin and Paclitaxel in advanced breast cancer patients enrolled into a…”
Get full text

2090P Management of trastuzumab deruxtecan-related nausea and vomiting in real-world practice by Licata, L., Notini, G., Sica, L., Viale, G., Zambelli, S., Rognone, A., Aldrighetti, D., Piras, M., Nuccio, A., Zucchinelli, P., Bianchini, G.

Get full text

5075 Sunitinib plus docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer by Cardoso, F, Canon, J.L, Amadori, D, Dirix, L, Villa, E, Aldrighetti, D, Machiels, J.P, Verkh, L, Kern, K, Giorgetti, C

Get full text

O-54 Switching to an aromatase inhibitor provides mortality benefit in early breast-carcinoma: Pooled analysis of 2 consecutive trials by Boccardo, F, Rubagotti, A, Aldrighetti, D, Buzzi, F, Cruciani, G, Farris, A, Mustacchi, G, Porpiglia, M, Schieppati, G, Sismondi, P

Get full text

Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma: Results from the Gruppo Oncologico Nord Ovest Randomized Trial by CONTE, Pier Franco, GUARNERI, Valentina, CARNINO, Flavio, GIANNESSI, Piergiorgio, COSTANTINI, Massimo, MOYANO, Alfredo, BALDINI, Editta, BRUZZI, Paolo, PROCHILO, Tiziana, SALVADORI, Barbara, BOLOGNESI, Angelo, ALDRIGHETTI, Daniela, VENTURINI, Marco, ROSSO, Riccardo, MAMMOLITI, Serafina

“…Abstract BACKGROUND The authors performed a randomized trial comprising patients with metastatic breast carcinoma (MBC). They used a noninferiority design to…”
Get full text

Randomized phase II study of weekly versus every 3 week ixabepilone plus bevacizumab (ixa/bev) versus paclitaxel plus bev (pac/bev) as first-line therapy for metastatic breast cancer (MBC): Final results by Rugo, H. S., Campone, M., Amadori, D., Wardley, A. M., Aldrighetti, D., Conte, P. F., Liu, D., Mudenda, B., McHenry, M. B., Pivot, X. B.

“…Abstract only…”
Get full text

Tolerability of sunitinib in combination with docetaxel and trastuzumab as first-line therapy for HER2+ advanced breast cancer by Cardoso, F, Canon, J, Amadori, D, Dirix, L, Villa, E, Aldrighetti, D, Machiels, J, Verkh, L, Huang, X, Giorgetti, C

“…Abstract Abstract #4120 Background: Trastuzumab (T) combined with docetaxel (D) is approved for the first-line treatment of HER2+ advanced BC (ABC). Sunitinib…”
Get full text

An Exploratory Study of Sunitinib (SU) Plus Docetaxel (D) and Trastuzumab (T) for First-Line Therapy of HER2+ Advanced Breast Cancer (ABC) by Dirix, L., Canon, J., Amadori, D., Villa, E., Aldrighetti, D., Machiels, J., Verkh, L., Bouko, Y., Kern, K., Giorgetti, C., Cardoso, F.

“…Abstract Background: T + D is a standard 1st-line treatment (tx) for HER2+ ABC (locally recurrent or metastatic BC). SU is an oral, multitargeted tyrosine…”
Get full text

Anthracycline-based sequential adjuvant chemotherapy in operable breast cancer: Five-year results of a randomized study by the Michelangelo Foundation by Moliterni, A., Mansutti, M., Aldrighetti, D., Merlini, L., Zuccarino, L., Bari, M., Farris, A., Mariani, P., Fava, S., Gianni, L.

“…Abstract only 535 Background: Anthracycline-based sequential chemotherapy significantly improves efficacy outcomes compared to CMF alone. Methods: 806 eligible…”
Get full text

Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it by Boccardo, F, Rubagotti, A, Amoroso, D, Mesiti, M, Romeo, D, Sismondi, P, Giai, M, Genta, F, Pacini, P, Distante, V, Bolognesi, A, Aldrighetti, D, Farris, A

“…To compare the efficacy of chemotherapy versus that of tamoxifen plus ovarian suppression in pre-/perimenopausal estrogen receptor-positive patients with early…”
Get full text

Epirubicin (E) plus paclitaxel (P) vs epirubicin followed by paclitaxel in metastatic breast cancer (MBC): an ongoing pharmacoeconomic study by Redaelli, A., Baldini, E., Salvadori, B., Aldrighetti, D., Conte, P.F., Quattrocchio, M., Svanosio, M., Bergamino, T., Tibaldi, C., Lionetto, R.

Get full text

Comment on "The Goal of Intraoperative Blood Loss in Major Hepatectomy Resection for Perihilar Cholangiocarcinoma Saving Patients From a Heavy Complication Burden" by Ratti, Francesca, Marino, Rebecca, Aldrighetti, Luca

Get full text

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma” by Famularo, Simone, Donadon, Matteo, Cipriani, Federica, Aldrighetti, Luca, Trevisani, Franco, Torzilli, Guido

Get full text

Surgical Management of Patients with Synchronous Colorectal Liver Metastasis: A Multicenter International Analysis by Mayo, Skye C., MD, MPH, Pulitano, Carlo, MD, Marques, Hugo, MD, Lamelas, Jorge, MD, Wolfgang, Christopher L., MD, PhD, FACS, de Saussure, Wassila, MD, Choti, Michael A., MD, MBA, Gindrat, Isabelle, MD, Aldrighetti, Luca, MD, Barrosso, Eduardo, MD, Mentha, Gilles, MD, Pawlik, Timothy M., MD, MPH, PhD, FACS

“…Background The goal of this study was to investigate the surgical management and outcomes of patients with primary colorectal cancer (CRC) and synchronous…”
Get full text

PP-5-5 CMF vs Tamoxifen (TAM) Plus Goserelin (GOS) as Adjuvant Treatment of ER Positive (+VE) Pre-Perimenopausal Breast Cancer Patients (PTS). Preliminary Results of an Ongoing Italian Breast Cancer Adjuvant Study Group (GROCTA) Trial by Boccardo, F., Rubagotti, A., Amoroso, D., Mesiti, M., Geraci, O., Delia, P., Villa, E., Aldrighetti, D., Genta, F., De Sanctis, C., Irtelli, L, Donati, D., Pacini, P., Scotto, T., Schieppati, G.

Get full text

Laparoscopic Parenchymal-Sparing Resections for Nonperipheral Liver Lesions, the Diamond Technique: Technical Aspects, Clinical Outcomes, and Oncologic Efficiency by Cipriani, Federica, MD, Shelat, Vishal G., MD, FRCS, FICS, Rawashdeh, Majd, MD, Francone, Elisa, MD, Aldrighetti, Luca, MD, PhD, Takhar, Arjun, MD, FRCS, PhD, Armstrong, Thomas, MD, FRCS, PhD, Pearce, Neil W., MD, FRCS, Abu Hilal, Mohammad, MD, FRCS, PhD, DocEurp

“…Background Surgical management of liver lesions has moved toward “parenchymal-sparing” strategies. Although open parenchymal-sparing liver resections are…”
Get full text

0.31. CMF vs tamoxifen (TAM) plus goserelin (GOS) as adjuvant treatment of ER positive (+VE) preperimenopausal breast cancer patients (pts). Preliminary results of an ongoing Italian breast cancer adjuvant study group (GROCTA) trial by Boccardo, F., Rubagotti, A., Amoroso, D., Mesiti, M., Geraci, O., Delia, P., Villa, E., Aldrighetti, D., Genta, F., Sismondi, P., Irtelli, L., Donati, D., Paccini, P., Farris, A., Schieppati, G.

Get full text

Intrahepatic Cholangiocarcinoma: Prognosis of Patients Who Did Not Undergo Lymphadenectomy by Bagante, Fabio, MD, Gani, Faiz, MBBS, Spolverato, Gaya, MD, Xu, Li, MD, Alexandrescu, Sorin, MD, Marques, Hugo P., MD, Lamelas, Jorge, MD, Aldrighetti, Luca, MD, Gamblin, T. Clark, MD, FACS, Maithel, Shishir K., MD, FACS, Pulitano, Carlo, MD, Bauer, Todd W., MD, FACS, Shen, Feng, MD, Poultsides, George A., MD, FACS, Marsh, J. Wallis, MD, FACS, Pawlik, Timothy M., MD, MPH, PhD, FACS

“…Background The role of routine lymphadenectomy (LD) among patients undergoing surgery for intrahepatic cholangiocarcinoma (ICC) remains poorly defined. This…”
Get full text

Lack of Effectiveness of Adjuvant Alternating Chemotherapy in Node-Positive, Estrogen-Receptor-Negative Premenopausal Breast Cancer Patients: Results of a Multicentric Italian Study by Boccardo, Francesco, Rubagotti, Alessandra, Amoroso, Domenico, Perrotta, Alessandra, Sismondi, Piero, Farris, Antonio, Mesiti, Mario, Gallo, Luigi, Pacini, Paolo, Villa, Eugenio, Agostara, Biagio

“…A multicentric randomized trial was performed in premenopausal women with node-positive, estrogen-receptor-negative breast tumors to assess the potential…”
Get full text